329 related articles for article (PubMed ID: 10576048)
1. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
Jurewicz WA
Transplant Proc; 1999 Nov; 31(7A):64S-66S. PubMed ID: 10576048
[No Abstract] [Full Text] [Related]
2. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
Friemann S; Feuring E; Padberg W; Ernst W
Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504
[No Abstract] [Full Text] [Related]
3. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
Yu L; Wang Y; Fu SJ; Cheng XJ
Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
[No Abstract] [Full Text] [Related]
4. Triple therapy with mycophenolate mofetil versus azathioprine.
Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
[No Abstract] [Full Text] [Related]
5. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
[No Abstract] [Full Text] [Related]
6. Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
Vanrenterghem Y; Squifflet JP; Forsythe J; Heeman U; Bäckman L; Taube D; Morales JM; Ekberg H; van Hooff J; Zanker B; Dietl KH; Talbot D; Hauser I; Tydén G; Claesson K; Mühlbacher F
Transplant Proc; 1998 Jun; 30(4):1290-1. PubMed ID: 9636523
[No Abstract] [Full Text] [Related]
7. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
Suhail SM; Vathsala A; Lou HX; Woo KT
Transplant Proc; 2000 Nov; 32(7):1757-8. PubMed ID: 11119922
[No Abstract] [Full Text] [Related]
8. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
9. Clinical study of FK 506 in renal transplant recipients.
Youhua Z; Zhinlian M; Liming W
Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900
[No Abstract] [Full Text] [Related]
10. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
[No Abstract] [Full Text] [Related]
11. Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes.
Sundberg AK; Smith LD; Somerville KT; Cox R; Sherbotie JR
Transplant Proc; 2002 Aug; 34(5):1951-2. PubMed ID: 12176640
[No Abstract] [Full Text] [Related]
12. Tacrolimus therapy for ABO-incompatible kidney transplantation.
Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
[No Abstract] [Full Text] [Related]
13. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
[No Abstract] [Full Text] [Related]
14. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
[TBL] [Abstract][Full Text] [Related]
15. Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation.
Zuckermann A; Birsan T; Thaghavi S; Kupilik N; Deviatko E; Dekan G; Wolner E; Klepetko W
Transplant Proc; 1999; 31(1-2):1160-1. PubMed ID: 10083518
[No Abstract] [Full Text] [Related]
16. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
Nakache R; Weinbroum A; Merhav H; Katz P; Kaplan E
Transplant Proc; 2001 May; 33(3):2294-5. PubMed ID: 11377533
[No Abstract] [Full Text] [Related]
17. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
Pascual J; Ortuño J;
Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198
[No Abstract] [Full Text] [Related]
18. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
19. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
Forsythe J
Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
[No Abstract] [Full Text] [Related]
20. A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.
Thervet E; Morelon E; Ducloux D; Bererhi L; Noël LH; Janin A; Bedrossian J; Puget S; Chalopin JM; Mihatsch M; Legendre C; Kreis H
Transplant Proc; 2000 Dec; 32(8):2778. PubMed ID: 11134800
[No Abstract] [Full Text] [Related]
[Next] [New Search]
